Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Russell GC, Benavides J, Grant D, Todd H, Deane D, Percival A, Thomson J, Connelly M, Haig DM.

Vet Res. 2012 Jun 11;43:51. doi: 10.1186/1297-9716-43-51.

2.

The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.

Parameswaran N, Russell GC, Bartley K, Grant DM, Deane D, Todd H, Dagleish MP, Haig DM.

Vet Res. 2014 May 27;45:59. doi: 10.1186/1297-9716-45-59.

3.

An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Haig DM, Grant D, Deane D, Campbell I, Thomson J, Jepson C, Buxton D, Russell GC.

Vaccine. 2008 Aug 18;26(35):4461-8. doi: 10.1016/j.vaccine.2008.06.056. Epub 2008 Jul 2.

PMID:
18601965
4.

Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.

Bartley K, Deane D, Percival A, Dry IR, Grant DM, Inglis NF, Mclean K, Manson ED, Imrie LH, Haig DM, Lankester F, Russell GC.

Vet Microbiol. 2014 Sep 17;173(1-2):17-26. doi: 10.1016/j.vetmic.2014.07.004. Epub 2014 Jul 15.

PMID:
25091530
5.

The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen® and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.

Lankester F, Lugelo A, Werling D, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Smith S, Parameswaran N, Cleaveland S, Russell G, Haig D.

Vet Microbiol. 2016 Nov 15;195:144-153. doi: 10.1016/j.vetmic.2016.09.019. Epub 2016 Sep 23.

6.

Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.

Taus NS, O'Toole D, Herndon DR, Cunha CW, Warg JV, Seal BS, Brooking A, Li H.

Vet Microbiol. 2014 Aug 6;172(1-2):318-22. doi: 10.1016/j.vetmic.2014.04.003. Epub 2014 Apr 13.

PMID:
24803260
7.

A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

Lankester F, Russell GC, Lugelo A, Ndabigaye A, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Percival A, Deane D, Haig DM, Cleaveland S.

Vaccine. 2016 Feb 3;34(6):831-8. doi: 10.1016/j.vaccine.2015.12.009. Epub 2015 Dec 17.

8.

Small RNA deep sequencing identifies viral microRNAs during malignant catarrhal fever induced by alcelaphine herpesvirus 1.

Sorel O, Tuddenham L, Myster F, Palmeira L, Kerkhofs P, Pfeffer S, Vanderplasschen A, Dewals BG.

J Gen Virol. 2015 Nov;96(11):3360-72.

PMID:
26329753
9.

A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.

van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ.

Vaccine. 1994 Nov;12(14):1295-302.

PMID:
7856294
10.

Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine.

Van der Poel WH, Kramps JA, Quak J, Brand A, Van Oirschot JT.

Vet Rec. 1995 Sep 30;137(14):347-8.

PMID:
8560685
11.
13.

Characterization of ovine herpesvirus 2-induced malignant catarrhal fever in rabbits.

Li H, Cunha CW, Gailbreath KL, O'Toole D, White SN, Vanderplasschen A, Dewals B, Knowles DP, Taus NS.

Vet Microbiol. 2011 Jun 2;150(3-4):270-7. doi: 10.1016/j.vetmic.2011.02.016. Epub 2011 Feb 23.

14.

Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.

Campos FS, Dezen D, Antunes DA, Santos HF, Arantes TS, Cenci A, Gomes F, Lima FE, Brito WM, Filho HC, Batista HB, Spilki FR, Franco AC, Rijsewijk FA, Roehe PM.

Vet Microbiol. 2011 Feb 24;148(1):18-26. doi: 10.1016/j.vetmic.2010.08.004. Epub 2010 Aug 17.

PMID:
20828945
15.

A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.

Makoschey B, Beer M.

Berl Munch Tierarztl Wochenschr. 2007 Nov-Dec;120(11-12):480-2.

PMID:
18085158
16.

Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.

Myster F, Palmeira L, Sorel O, Bouillenne F, DePauw E, Schwartz-Cornil I, Vanderplasschen A, Dewals BG.

J Virol. 2015 Apr;89(7):3630-47. doi: 10.1128/JVI.03634-14. Epub 2015 Jan 14.

17.

Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.

Silva AD, Spilki FR, Franco AC, Esteves PA, Hübner SO, Driemeier D, Oliveira AP, Rijsewijk F, Roehe PM.

Vaccine. 2006 Apr 12;24(16):3313-20. Epub 2006 Jan 25.

PMID:
16480790
19.

Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.

Lemaire M, Schynts F, Meyer G, Georgin JP, Baranowski E, Gabriel A, Ros C, Belák S, Thiry E.

Vaccine. 2001 Sep 14;19(32):4795-804.

PMID:
11535332
20.

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.

Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.

Vet Immunol Immunopathol. 2005 May 1;105(1-2):47-57.

PMID:
15797474

Supplemental Content

Support Center